UnitedHealth Group reported $5.5 billion in second quarter profits as its insurance plans and Optum businesses grew by double digit percentages despite rising costs.
India is a ticking time bomb when it comes to non-communicable diseases, with over 100 million people with diabetes. India urgently needs a comprehensive, well-funded plan to deal with diabetes and NCDs.
The 2016 death of a Black mother at one of the largest medical centers in Los Angeles not only sparked national controversy, but is also linked to a new federal investigation.
The patch is called a TaoPatch and is produced by an Italian company that claims the device can boost athletic performance, improve diseases like multiple sclerosis and build stamina.
The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson’s tuberculosis drug in 44 more countries.
Norgestrel—sold under the brand name Opill—is considered a mini pill, which is safer for more people to take than the combination birth control pill because the chance of developing cervical and breast cancer and blood clotting is lower.
The Food and Drug Administration on Thursday approved the first ever over-the-counter birth control daily pill, a major development amid a heightened debate over contraception in the wake of the Supreme Court’s momentous decision last summer.
Almost 2,000 people have been infected with norovirus on cruise ships this year, meaning there are more norovirus cases at sea halfway through 2023 than there were in 2022.